MScreen: an integrated compound management and high-throughput screening data storage and analysis system.

High-throughput screening (HTS) has historically been used by the pharmaceutical industry to rapidly test hundreds of thousands of compounds to identify potential drug candidates. More recently, academic groups have used HTS to identify new chemical probes or small interfering RNA (siRNA) that can serve as experimental tools to examine the biology or physiology of novel proteins, processes, or interactions. HTS presents a significant challenge with the vast and complex nature of data generated. This report describes MScreen, a Web-based, open-source cheminformatics application for chemical library and siRNA plate management, primary HTS and dose-response data handling, structure search, and administrative functions. Each project in MScreen can be secured with passwords or shared in an open-information environment that enables collaborators to easily compare data from many screens, providing a useful means to identify compounds with desired selectivity. Unique features include compound, substance, mixture, and siRNA plate creation and formatting; automated dose-response fitting and quality control (QC); and user, target, and assay method administration. MScreen provides an effective means to facilitate HTS information handling and analysis in the academic setting so that users can efficiently view their screening data and evaluate results for follow-up.

[1]  John S Lazo,et al.  Building a Pharmacological Lexicon: Small Molecule Discovery in Academia , 2007, Molecular Pharmacology.

[2]  Mark Watson,et al.  Optimizing the use of open-source software applications in drug discovery. , 2006, Drug discovery today.

[3]  G. Rishton Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.

[4]  Alnawaz Rehemtulla,et al.  Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules* , 2009, The Journal of Biological Chemistry.

[5]  B. Ross,et al.  Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity. , 2007, Analytical biochemistry.

[6]  David J. Miller,et al.  Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses. , 2009, The Journal of infectious diseases.

[7]  John P. Sullivan,et al.  Screensaver: an open source lab information management system (LIMS) for high throughput screening facilities , 2010, BMC Bioinformatics.

[8]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[9]  Sitta Sittampalam,et al.  Open access high throughput drug discovery in the public domain: a Mount Everest in the making. , 2010, Current pharmaceutical biotechnology.

[10]  Marc Ferrer,et al.  Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.

[11]  Richard R Neubig,et al.  Polyplexed Flow Cytometry Protein Interaction Assay: A Novel High-Throughput Screening Paradigm for RGS Protein Inhibitors , 2009, Journal of biomolecular screening.

[12]  R. Neubig,et al.  Complementary Cell-Based High-Throughput Screens Identify Novel Modulators of the Unfolded Protein Response , 2011, Journal of biomolecular screening.

[13]  D. Auld,et al.  Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology. , 2010, Chemistry & biology.